Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from EVE Health Group Limited ( (AU:EVE) ) is now available.
EVE Health Group has successfully completed its Share Purchase Plan (SPP), allowing eligible shareholders to purchase new fully paid ordinary shares at $0.036 per share, the same price as a recent placement. The company received applications totaling $32,500, resulting in the issuance of 902,766 new shares, which will rank equally with existing shares, potentially strengthening its financial position and shareholder base.
More about EVE Health Group Limited
EVE Health Group (ASX: EVE) is an Australian-based health company that focuses on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries, Meluka Australia and Nextract, EVE delivers science-led innovations to support consumer and practitioner health across retail, pharmacy, and clinical channels.
Average Trading Volume: 983,378
Technical Sentiment Signal: Sell
Current Market Cap: A$8.59M
For detailed information about EVE stock, go to TipRanks’ Stock Analysis page.